19210
Butyric acid
puriss., ≥99.5% (GC)
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
CH3CH2CH2COOH
CAS Number:
Molecular Weight:
88.11
EC Number:
203-532-3
UNSPSC Code:
12352100
MDL number:
Beilstein/REAXYS Number:
906770
vapor density
3.04 (vs air)
vapor pressure
0.43 mmHg ( 20 °C)
grade
puriss.
assay
≥99.5% (GC)
autoignition temp.
824 °F
expl. lim.
10 %
refractive index
n20/D 1.398
bp
162 °C (lit.)
mp
−6-−3 °C (lit.)
density
0.964 g/mL at 25 °C (lit.)
SMILES string
CCCC(O)=O
InChI
1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6)
InChI key
FERIUCNNQQJTOY-UHFFFAOYSA-N
Still not finding the right product?
Explore all of our products under Butyric acid
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Dam. 1 - Skin Corr. 1B - STOT SE 3
target_organs
Respiratory system
Storage Class
8A - Combustible corrosive hazardous materials
wgk
WGK 1
flash_point_f
161.6 °F - closed cup
flash_point_c
72 °C - closed cup
ppe
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
J J Mallo et al.
Journal of animal science, 90 Suppl 4, 227-229 (2013-02-13)
Three tests, 2 in vivo and 1 in vitro, were conducted to compare how 2 forms of protection of butyric acid (BA) affect its liberation along the gastrointestinal tract (GIT) of piglets. The 2 forms of BA were vegetable fat-encapsulated
Naofumi Kaneko et al.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 132(7), 849-853 (2012-07-14)
Antimicrobial agents occasionally cause certain adverse effects, such as diarrhea and loose stool, by altering the composition of the intestinal flora. Antibiotic-resistant lactic acid bacteria are used to prevent these adverse effects. Although these bacteria are not resistant to several
Mirosława Gałecka et al.
Polish journal of microbiology, 62(1), 91-95 (2013-07-09)
The aim of the study was evaluation of the correlation between the level of clinical activity of Crohn's disease (CD) and the number of Faecalibacterium prausnitzii, total number of bacteria and the concentration of selected short chain fatty acids (SCFA)